UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 11, 2024

Accession Number:	0001193125-24-064463
Submission Type:	POS AM
CIK: 0001708493 Company Name: Harpoon Therapeutics, Inc. File Number: 333-272064